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PCardiac Imaging
iagnostic Performance of Coronary
agnetic Resonance Angiography as
ompared Against Conventional X-Ray Angiography
Meta-Analysis
eter G. Danias, MD, PHD, FACC,*†‡ Arkadios Roussakis, MD,† John P. A. Ioannidis, MD§
thens and Ioannina, Greece; and Boston, Massachusetts
OBJECTIVES This study was designed to define the current role of coronary magnetic resonance
angiography (CMRA) for the diagnosis of coronary artery disease (CAD).
BACKGROUND Coronary magnetic resonance angiography has been proposed as a promising noninvasive
method for diagnosis of CAD, but individual studies evaluating its clinical value have been of
limited sample size.
METHODS We identified all studies (MEDLINE and EMBASE) that evaluated CAD by both CMRA
and conventional angiography in 10 subjects during the period 1991 to January 2004. We
recorded true and false positive and true and false negative CMRA assessments for detection
of CAD using X-ray angiography as the reference standard. Analysis was done at segment,
vessel, and subject level.
RESULTS We analyzed 39 studies (41 separate comparisons). Across 25 studies (27 comparisons) with
data on 4,620 segments (993 subjects), sensitivity and specificity for detection of CAD were
73% and 86%, respectively. Vessel-level analyses (16 studies, 2,041 vessels) showed sensitivity
75% and specificity 85%. Subject-level analyses (13 studies, 607 subjects) showed sensitivity
88% and specificity 56%. At the segment level, sensitivity was 69% to 79% for all but the left
circumflex (61%) coronary artery; specificity was 82% to 91%. There was considerable
between-study heterogeneity, but weighted summary receiver-operating characteristic curves
agreed with these estimates. There were no major differences between subgroups based on
technical or population characteristics, year of publication, reported blinding, or sample size.
CONCLUSIONS In evaluable segments of the native coronary arteries, CMRA has moderately high sensitivity
for detecting significant proximal stenoses and may have value for exclusion of significant
multivessel CAD in selected subjects considered for diagnostic catheterization. (J Am Coll
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.07.051Cardiol 2004;44:1867–76) © 2004 by the American College of Cardiology Foundation
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wmaging of the coronary artery lumen is currently best
valuated with X-ray angiography with selective intracoro-
ary contrast injection. Besides establishing the diagnosis of
oronary artery disease (CAD), angiographic data regarding
uminal stenoses guide the selection between medical and
nterventional/surgical therapies. The number of diagnostic
ardiac catheterizations has been steadily increasing over the
ast few years (1). This comes at a considerable cost, and
hough the complication rate for each individual is propor-
ionally small (2), in total, cardiac catheterizations account
or considerable procedure-related morbidity. A noninvasive
iagnostic alternative is desirable.
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esearch and Technology-Hellas, Ioannina, Greece; and the Institute for Clinical
esearch and Health Policy Studies, Tufts-New England Medical Center, Boston,
assachusetts.v
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004, accepted July 29, 2004.Among proposed alternatives, coronary magnetic reso-
ance angiography (CMRA) offers high spatial resolution,
liminates the need for iodinated contrast, and does not
nvolve exposure to ionizing radiation. The many technical
hallenges have been addressed with various approaches,
nd CMRA has been the focus of clinical research over the
ast decade. Using two-dimensional (2D) CMRA, initial
ncouraging results (3) were followed by less optimistic
eports (4), thus creating confusion on whether CMRA can
ave a clinical role in the evaluation of CAD. Subsequent
eports with 2D CMRA (5–12) and three-dimensional
3D) CMRA (13–45) continued to show a seemingly broad
ange of sensitivity and specificity for detection of proximal
AD. It is unknown whether this variability has been due
o chance or reflects differences in hardware platform,
echnique implementation, and subject selection criteria.
tudies conducted to date have been of limited size, and
hus the confidence intervals for the observed sensitivity and
pecificity are large. Given the sample size limitations,
ingle studies have even less power for documenting
hether CMRA might perform better for specific coronary
essels. To address these issues and to provide an evidence-
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Magnetic Resonance Angiography to Diagnose CAD November 2, 2004:1867–76ased evaluation of the clinical utility of this new imaging
odality, we performed a comprehensive meta-analysis of
ll currently available studies comparing CMRA with con-
entional X-ray coronary angiography.
ETHODS
ligibility criteria and search strategy. We considered all
tudies published in English, French, or German evaluating
he presence of significant CAD in native coronary arteries
y both CMRA and X-ray angiography in the same
ubjects. Studies were eligible regardless of whether they
eferred to subjects with suspected or proven CAD and
egardless of technique used for CMRA. We excluded
tudies with fewer than 10 subjects examined with both
ethods, as these would be unlikely to contribute meaning-
ul diagnostic information. Studies evaluating vessel patency
lone, phantom-only evaluations, and animal studies were
xcluded. Studies limited exclusively to subjects with normal
oronaries and studies assessing coronary grafts were also
xcluded.
We identified eligible studies by searching MEDLINE
nd EMBASE (last search January 2004). The search
ombined exploded keywords pertaining to CAD and
MRA (strategy available upon request). In addition, we
erused bibliographies of retrieved articles and reviews. The
etrieved studies were carefully examined to exclude dupli-
ation or overlap of subjects. Duplicate/overlapping data
ere counted only once in the meta-analysis, unless the
ame subjects had been evaluated at different time points
nd/or with different CMRA techniques. When a single
tudy included more than one well-defined subject group or
MRA techniques, each group/approach was considered as
separate comparison. We communicated with all corre-
ponding investigators of the identified reports to clarify
nclear data and to obtain key data that were not reported
n the articles. Meeting abstracts were excluded, as they
ould not provide adequately detailed data and their results
ight not be final.
ata extraction. The following information was extracted
rom each pertinent study: first author, year of publication,
nd journal; study population characteristics including sam-
le size (number of subjects evaluated with both tests and
umber of subjects evaluated with X-ray angiography only);
ercentage of subjects with documented CAD; gender;
Abbreviations and Acronyms
CAD  coronary artery disease
CMRA  coronary magnetic resonance angiography
SROC  summary receiver-operating characteristic
3D  three-dimensional
2D  two-dimensionalean (or median) age (and standard deviation); relative diming of the two imaging procedures and blinding of
valuators of one test to the results of the other and to the
linical condition of the tested subject; technical character-
stics of the CMRA (including electrocardiogram gating
nd fat signal suppression [yes/no], respiratory motion
uppression method [breath-holding vs. navigator (retro-
pective vs. prospective)], mode of acquisition [2D vs. 3D],
cho and repetition times, spatial and temporal resolution);
nd hardware platform.
We recorded the true positive, false negative, false posi-
ive, and true negative CMRA assessments for detection of
AD using X-ray angiography as the reference standard.
he 50% diameter stenosis cutoff was selected as the
riterion for significant CAD, unless only a different thresh-
ld had been used. Data were recorded separately, whenever
vailable, at the level of segments, vessels, and subjects.
eparate data were also recorded at the segment level for
ndividual major epicardial vessels (left main, left anterior
escending, left circumflex, and right coronary arteries). All
iagnostic accuracy estimates pertain to evaluable segments/
essels/subjects. Detailed data are available upon request.
Two investigators (A.R., P.G.D.) performed the data
xtraction independently. Discrepancies were solved by
onsensus and with discussion with the third investigator
J.P.A.I.). Databases were enhanced with additional data
rovided directly by primary investigators of several studies.
ata synthesis. The main analysis was performed at the
evel of coronary artery segments, as most studies focused on
his level of information. Secondary analyses combined the
vailable vessel-level data and subject-level data. Separate
egment-level analyses were performed also for each coro-
ary vessel and for prespecified subgroups, defined so as to
nvestigate the potential effect of key characteristics of the
MRA technique (acquisition technique [2D vs. 3D] and
espiratory motion compensation technique), temporal evo-
ution (year of publication [1991 to 2000 vs. 2001 to 2004]),
tudy population characteristics (inclusion or not of subjects
ithout CAD), potential for bias (reading of CMRA stated
r not to be blind to the results of X-ray angiography and to
linical data; small vs. larger studies), and segments consid-
red (including or not distal segments).
Sensitivity and specificity estimates for each analysis were
ndependently combined across studies using a random
ffects model that weighs each proportion by the inverse of
he sum of its variance and the between-study variance (46).
etween-study heterogeneity was assessed for the sensitivity
nd specificity estimates using the chi-square test with n 
degrees of freedom (n is the number of studies) and Fisher
xact test when numbers were small. Because sensitivity and
pecificity are interdependent, independent weighting may
ometimes give spurious results and underestimate both
arameters. Therefore, we also estimated weighted and
nweighted summary receiver-operating characteristic
SROC) curves (47) that have been established as the most
ppropriate approach to bypass this problem of interdepen-
ence. The SROC curves are estimated from D  a  bS,
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November 2, 2004:1867–76 Magnetic Resonance Angiography to Diagnose CADhere D is the difference of the logits (log odds) of the true
ositives (sensitivity) and false positives (1 specificity) and
is the sum of these logits. When b is 0, the SROC curve
s symmetric around the diagonal. Conversely, when b is
ignificantly different from 0, the SROC curve is not
ymmetrical, and this suggests that the overall diagnostic
erformance varies in different parts of the curve, with
nequal tradeoff between sensitivity and specificity across
tudies. This indicates significant heterogeneity across stud-
es in the thresholds used, the study populations, or other
arameters. Summary receiver-operating characteristic
urves should not be extrapolated outside the range of
bserved values. Unweighted SROC curves consider all
tudies equally in the calculations, whereas weighted SROC
able 1. Study and Population Characteristics
Author, Year (Ref.)
X-Ray
(CMRA)
CAD
(%)
Mean Age
(SD) or Range
(yrs)
M
(
anning, 1993 (3) 39 (39) 74 54
uerinckx, 1994 (4) 21 (20) 85 61 (8)
ohiaddin, 1996 (6) 16 (16) NR 57 (8) N
ost, 1997 (8) 35 (35) NR 58 (10)
oshino, 1997 (9) 76 (31) 100 61 (10)
itatori, (a) 1998 (10) 70 (70) 100 NR N
itatori, (b) 1998 (10) 43 (43) NR NR N
chmidt, 1999 (11) 29 (29) 100 60 (10)
atanuki, 2000 (12) 123 (108) 100 61 (11)
ost, 1996 (13) 20 (20) 75 58
essler, 1997 (14) 73 (65) NR 60
uller, 1997 (15) 35 (29) 83 61
shinski, 1998 (16) 13 (11) NR 57 N
oodard, 1998 (17) 10 (10) 100 60
uber, 1999 (18) 20 (20) 100 65 (7) N
ethimonnier, 1999 (19) 21 (17) NR 57
andstede, 1999 (20) 20 (19) 58 61 (9)
andstede, 1999 (21) 30 (23) 91 63 (9)
an Geuns, 1999 (22) 32 (29) 59 32–73
egenfus, 2000 (24) 50 (50) 72 61
ardanelli, 2000 (25) 42 (39) 87 65 (9)
an Geuns, 2000 (26) 38 (34) 68 43–72
unce, 2001 (27) 46 (46) 50 34–84
onshior, 2001 (28) 20 (20) 100 65 (8) N
im, 2001 (29) 109 (103) 58 59 (10)
ikolaou, (a) 2001 (30) 20 (20) 100 65 (8) N
ikolaou, (b) 2001 (30) 20 (20) 100 62 (10) N
an Geuns, 2001 (31) 13 (12) NR 60
ikolaou, 2002 (32) 20 (20) 100 63 (8)
lein, 2002 (33) 10 (10) 100 61
opers, 2002 (34) 118 (87) 17 64
ommer, 2002 (36) 112 (107) 59 62 N
an Geuns, 2002 (37) 27 (27) 70 38–76
atanabe, 2002 (38) 16 (12) 100 71
eber, 2002 (39) 15 (15) 73 61
ogaert, 2003 (40) 21 (19) 62 62 (5)
konen, 2003 (41) 69 (69) 68 58
lein, 2003 (42) 12 (10) NR 61 (5)
rittayaphong, 2003 (43) 61 (57) 67 63 (9)
lein, 2003 (44) 45 (50) 90 59
egenfus, 2003 (45) 61 (61) 75 63 (6)
Availability of 2  2 tables at the subject level (Su), vessel level (V), and segment l
C  clinical data; CAD  coronary artery disease; CMRA  coronary magneticurves weigh each study by the variance of D. tFinally, for the derived estimates of sensitivity and
pecificity for CAD at the subject level, we evaluated the
egative and positive predictive value among subjects
ith 5%, 20%, 50%, and 80% pretest probability of CAD.
he positive predictive value is calculated as pretest odds
(sensitivity/[1  specificity])/(1  [pretest odds 
sensitivity/[1  specificity])]). The negative predictive
alue is calculated as pretest odds  ([1  sensitivity]/
pecificity)/(1  [pretest odds  ([1  sensitivity]/
pecificity]).
oftware. Analyses were performed in SPSS 11.0 (SPSS
nc., Chicago, Illinois), Meta-Analyst (Joseph Lau, Boston,
assachusetts), Meta-Test (Joseph Lau) and StatXact 3.0
Cytel Inc., Boston, Massachusetts). All p values are
Time
Diff.
(days)
Blinding
Stated
Data*
(% Evaluable
Segments)
Distal
Segments
0–7 T, C Su, V No
0–60 T, C S No
0–240 T V No
0–29 T V No
0–7 T, C S No
NR — S No
NR — S No
0–14 — V No
0–14 T, C S No
0–21 T V No
0–7 — S (52%) No
0–1 T S No
0–21 T, C V No
0–30 T V No
0–10 T Su, S (100%) No
0–9 T S No
0–3 T Su, S (73%) No
0–4 T, C Su Yes (RCA only)
0–30 — Su, S No
0–3 T Su, S (77%) No
0–14 T, C Su, V, S Yes
0–30 T S Yes (RCA only)
0–90 T V No
0–10 T, C S No
0–14 T, C Su, V No
0–10 T, C S (100%) No
0–10 T, C S (100%) No
NR T, C S No
0–10 T, C S (82%) No
90 65 T, C Su, V NR
1–3 T, C Su, V No
0–16 — S No
0–30 T, C S (69%) Yes (RCA only)
0 T S (70%) Yes
0–28 T Su, S (70%) Yes (LAD,RCA only)
0–1 T Su, V, S (70%) Yes
0–1 T, C Su, V No
0 T, C S No
0–1 T, C Su, V No
NR T, C Su, V Yes
0–3 T S (77%) No
).
ance angiography; NR  not reported; T  test (results of X-ray angiography).ale
%)
90
95
R
77
83
R
R
76
77
80
75
71
R
50
R
95
75
77
63
80
79
71
80
R
69
R
R
69
65
80
77
R
59
75
93
71
62
92
51
72
85wo-tailed.
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Magnetic Resonance Angiography to Diagnose CAD November 2, 2004:1867–76ESULTS
e identified 41 potentially eligible and apparently non-
verlapping studies (3–22,24–34,36–45) with 44 different
omparisons of CMRA against X-ray angiography. Supple-
ental data were provided by primary investigators for 13
tudies (14 comparisons). For two studies (5,7), we could
ot obtain sufficient information for constructing any com-
lete 2-by-2 table for any analysis. The remaining 39 studies
escribed 41 comparisons of the two imaging techniques in
total of 1,671 subjects with X-ray angiography, of whom
,522 also had CMRA data (91.1%). Twelve studies (12
omparisons) with 370 subjects included only subjects with
AD and these were not considered in subject-level anal-
able 2. Technical CMRA Characteristics
Author, Year (Ref.) Scanner Seq
anning, 1993 (3) Siemens Magnetom SP 2D
uerinckx, 1994 (4) Siemens Magnetom SP 2D
ohiaddin, 1996 (6) Picker Vista 2D
ost, 1997 (8) Siemens Magnetom SP 2D
oshino, 1997 (9) Siemens Magnetom Vision 2D
itatori, (a) 1998 (10) Siemens Magnetom Vision 2D
itatori, (b) 1998 (10) Siemens Magnetom Vision 2D
chmidt, 1999 (11) Philips Gyroscan NT/ACS 2D
atanuki, 2000 (12) Siemens Magnetom Vision 2D
ost, 1996 (13) Siemens Magnetom SP 3D
essler, 1997 (14) Siemens Magnetom Vision 3D
uller, 1997 (15) Siemens Magnetom Vision 3D
shinski, 1998 (16) Philips Gyroscan ACS/NT 3D
oodard, 1998 (17) Siemens Magnetom Vision 3D
uber, 1999 (18) Siemens Magnetom Vision 3D
ethimonnier, 1999 (19) GE Signa Echospeed 5–7 3D
andstede, 1999 (20) Siemens Magnetom Vision 3D
andstede, 1999 (21) Siemens Magnetom Vision 3D
an Geuns, 1999 (22) Siemens Magnetom Vision 3D
egenfus, 2000 (24) Siemens Magnetom Vision 3D c
ardanelli, 2000 (25) Philips Gyroscan ACS/NT 3D
an Geuns, 2000 (26) Siemens Magnetom Vision 3D c
unce, 2001 (27) Siemens Magnetom Vision 3D
onshior, 2001 (28) Picker Edge 3D
im, 2001 (29) Siemens Magnetom Vision 3D
ikolaou, (a) 2001 (30) Siemens Magnetom Vision 3D
ikolaou, (b) 2001 (30) Siemens Magnetom Vision 3D
an Geuns, 2001 (31) Siemens Magnetom Vision 3D
ikolaou, 2002 (32) Siemens Magnetom Vision 3D
lein, 2002 (33) Philips Gyroscan NT Intera CV 3D
opers, 2002 (34) Siemens Magnetom Vision 3D c
ommer, 2002 (36) Philips Gyroscan Intera 3D
an Geuns, 2002 (37) Siemens Magnetom Vision 3D
atanabe, 2002 (38) Philips Gyroscan ACS/NT 3D
eber, 2002 (39) Philips Gyroscan ACS/NT 3D
ogaert, 2003 (40) Philips Gyroscan ACS/NT 3D
konen, 2003 (41) Siemens Magnetom Vision 3D
lein, 2003 (42) Philips Gyroscan ACS/NT 3D
rittayaphong, 2003 (43) Philips Gyroscan ACS/NT 3D
lein, 2003 (44) Philips Gyroscan NT Intera CV 3D
egenfus, 2003 (45) Siemens Vision 3D c
H  breath holding; MA  motion adaptive; NR  not reported; PN  prospec
R/TE  repetition time/echo time; 2D  two-dimensional; 3D  three-dimensioses because no specificity could be estimated in these studies. Of the remaining 29 comparisons (1,152 subjects),
did not specify how many subjects had CAD, whereas in
0 of the other 21 comparisons, patients with CAD made
p half or more of the study population. Study population
haracteristics are shown in Table 1 and technical charac-
eristics of the CMRA are shown in Table 2. All studies
sed gradient echo (bright blood) sequences and only four
tudies (24,26,34,45) used intravenous contrast enhance-
ent. Data acquisition was consistently gated to the elec-
rocardiographic signal and timed to diastole, and nulling of
he epicardial fat signal was employed.
Data on diagnostic accuracy were available for 25 studies
27 comparisons) (4,620 segments of 993 subjects) at the
RMC
TR/TE
(ms)
Temporal
Resolution
(ms)
In-Plane Spatial
Resolution
(mm)
BH 13/8 78–104 1.4–1.9 0.9
BH 13/8 117 1.6–2.1 0.9–1.2
BH 15.7/6.5 126 1.6 0.8
BH 12.6/7 88 or 113 1.8 1.0
BH 17/7.9 119–153 NR
BH 17/7.9 119–153 NR
BH 17/7.9 119–153 NR
PN 14/7 140 0.7–0.9 1.4–1.9
BH 17/7.9 119–153 NR
RN 8.4/2.9 260 1.2 2.3
RN 7.4/2.7 178 1.17 1.17
RN 7.4/3.6 118 1.95 0.98
PN 13/7 104 0.7–0.9 0.9–1.2
RN 8/3 NR 1.2 1.2
RN 7.4/2.7 178 1.2 1.4
PN 7.3/2.2 146 1.25 1.66
RN 6/2.4 NR 1.00 1.21
RN 7.3/2.7 230 1.17 1.17
RN 7.4/2.7 128 1.9 1.25
t BH 4.2/1.6 294 1.4 1.25
PN 7.7/2.2 71 0.7 1.0
t BH 5.3/2.3 110 1.9 1.25
RN 7.4/2.7 178 1.2 2.3
PN 12.9/4.3 NA 1.0–1.2 1.4–2.3
RN 7.4/2.7 178 1.2 1.4
RN 7.4/2.7 178 1.0 1.5
RN 6/2.4 144 1.0 1.5
BH 5.3/2.3 NR 1.9 1.25
RN 6/2.4 144 1.0 1.5
PN 7/2.1 140–200 0.78 1.04
t RN 7.4/2.7 125 1.17 1.17
PN 7.4/2.2 82 0.70 0.79
RN 8/3 128 1.9 1.25
PN 9.4/2.7 56 0.65 0.92
PN 8/4 96 0.7 0.7
PN 7.1/1.97 70 0.7  1
RN 600–800/2.7 118 1.17 1.17
PN 8/2.3 52 0.9 0.7
PN 7.7/2.2 NR 0.7 1
PN MA 7.4/2.5 78–200 0.78 1.04
t BH 4.2/1.6 NR 1.4 1.25
avigator; RMC  respiratory motion compensation; RN  retrospective navigator;uence
ontras
ontras
ontras
ontrasegment level, 16 studies (2,041 vessels of 624 subjects) at
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November 2, 2004:1867–76 Magnetic Resonance Angiography to Diagnose CADhe vessel level, and 13 studies (n 607) at the subject level.
he vast majority of studies defined significant CAD by
sing the 50% stenosis cutoff. However, two studies (34,44)
sed 70% as the cutoff for CAD; one other study (17)
ncluded patients with 30% stenoses, and all patients had
40% vessel diameter stenosis by conventional X-ray cor-
nary angiography.
There was significant between-study heterogeneity in the
ensitivity and specificity estimates in all analyses (Table 3),
ith the exception of the sensitivity estimates at the subject
evel that consistently showed high sensitivity (range 73% to
00%), whereas specificity varied widely across studies.
eighted random effects independent estimates fell very
lose to the weighted SROC curve (Fig. 1), suggesting that
hey are appropriate approximations of the overall diagnos-
ic performance. Unweighted SROC curves were somewhat
ore favorable than weighted SROC curves, suggesting
hat smaller studies tended to show slightly more favorable
iagnostic performance than larger studies. The SROC
urve for the segment-level analysis showed statistically
ignificant asymmetry: across studies, specificity diminished
ithout any gains in sensitivity beyond 85% to 90%. The
verall weighted estimate suggested a sensitivity of 73%
ith specificity of 86%. However, there seemed to be
lusters of studies: one with low sensitivity (70%) and high
pecificity (85%), another with high sensitivity (80%)
nd also high specificity (85%), and a third one with
ariable sensitivity (60% to 92%) and low specificity (50%
o 75%).
At the segment level, the diagnostic accuracy was rela-
ively similar for the left main, left anterior descending, and
ight coronary arteries, with 69% to 79% of the lesions being
etected, against a specificity of 81% to 91%. The sensitivity
as considerably lower for lesions in the left circumflex
oronary artery with only slightly over half the lesions being
etected, and without the specificity being any better
Table 3, Fig. 2). There was modest heterogeneity in
ensitivity estimates across studies. Heterogeneity reached
ormal statistical significance for the left anterior descending
nd the right coronary arteries, but not for the left main and
eft circumflex coronary arteries, possibly due to smaller
Table 3. Summary of Diagnostic Accuracy of C
Angiography in Evaluable Segments, Vessels, a
Analysis
Studies
(n)
W
Segment level 27 (4,620)
Left main† 19 (802)
LAD 21 (1,058)
LCx 21 (674)
RCA 21 (990)
Subject level 13 (607)
Vessel level 11 (1,271)
*Statistically significant (p  0.10) between-study heterogen
with the proximal segment of the LAD. These data were in
CI confidence interval; CMRA coronary magnetic re
circumflex; RCA  right coronary artery; RE  random effumbers. There was significant between-study heterogene- wty across studies for all specificity estimates. In the case of
he left main coronary artery this heterogeneity was totally
xplained by two studies (18,28) that paradoxically showed
ery low specificity (27%). These two studies, along with
nother report (4) that also showed50% specificity for the
eft anterior descending coronary artery, accounted for the
bserved between-study heterogeneity for this vessel’s seg-
ents as well. Absolute differences in specificity were less
ronounced between studies for the right and left circumflex
oronary arteries. Random effects weighted estimates fell
lose to the weighted SROC curve, whereas unweighted
ROC curves provided somewhat more favorable results.
here was no statistically significant asymmetry for any
ROC curve in these analyses.
Subgroup analyses at the segment level showed no evi-
ence that the diagnostic performance might differ statisti-
ally significantly across subgroups (p  0.05 for all
etween-subgroup heterogeneity in both sensitivity and
pecificity random effects estimates) (Table 4). Nevertheless,
here were trends suggesting somewhat paradoxically better
iagnostic performance in earlier studies, 2D studies, and
tudies using breath holding for respiratory motion com-
ensation.
We estimated that for subjects with 5%, 20%, 50%, and
0% pretest probability of CAD, a positive CMRA would
lightly increase the probability of CAD to 10%, 33%, 66%,
nd 89%, respectively. Given the same pretest probabilities,
negative test would decrease the risk of CAD to 1.1%, 5%,
8%, and 46%, respectively.
ISCUSSION
oronary magnetic resonance angiography has been a
romising alternative for invasive X-ray contrast angiogra-
hy and has been intensely investigated over the past several
ears. Our meta-analysis combined data on the diagnostic
erformance of CMRA that represent the experience of
any centers around the world. We showed that in subjects
ith intermediate/high likelihood for CAD, CMRA can
etect about three-quarters of significant stenoses in the
isualized segments of the major epicardial coronary arteries
A Against Conventional X-Ray
atients
hted Sensitivity Weighted Specificity
E (95% CI) RE (95% CI)
(69%–77%)* 86% (80%–90%)*
(56%–79%) 91% (84%–95%)*
(73%–84%)* 81% (71%–88%)*
(52%–69%) 85% (78%–90%)*
(64%–78%)* 84% (77%–88%)*
(82%–92%) 56% (43%–68%)*
(68%–80%)* 85% (78%–90%)*
four studies (22,26,37,41) evaluated the left main together
in the LAD analysis.
e angiography; LAD left anterior descending; LCx leftMR
nd P
eig
R
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ance in all vessels except the left circumflex coronary artery
possibly due to the close relationship with the accompany-
ng vein and adjacent blood pools of the left atrium and
entricle, and lower signal related to the greater distance
rom the receiving coil). Across populations with generally
igh prevalence of coronary stenoses, CMRA showed over-
igure 1. Summary receiver-operating characteristic (SROC) curves for th
he gold standard of X-ray coronary angiography using segment-level (A
omparison. Within each panel the diameters of the ellipses are inversely p
f specificity (horizontal diameter) of each comparison. Also shown is the
alculations () as well as the 95% confidence intervals (box). Weighted S
y thin lines.ll high sensitivity for identifying those with CAD, but gave salse positive readings in about half of the healthy subjects.
hus, CMRA may be particularly useful when it is negative
or decreasing the probability of CAD below 5%, especially
n individuals with modest suspicion for CAD, for example,
pretest probability for CAD below 20%.
One should recognize that the visual evaluation of con-
entional angiography may not be a perfect reference
gnostic performance of coronary magnetic resonance angiography against
ssel-level (B), and subject-level (C) data. Each ellipse corresponds to a
tional to the variance of the sensitivity (vertical diameter) and the variance
pendently weighted sensitivity and specificity according to random effects
curves are shown with bold lines; unweighted SROC curves are showne dia
), ve
ropor
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ther biases such as reporting bias may have led to overes-
imation of CMRA performance.
The technical aspects of CMRA are quickly evolving. For
xample, 3D imaging is now routinely performed by most
enters. Nevertheless, we did not observe any statistically
ignificant differences in the diagnostic performance of
arlier studies using less advanced techniques, as compared
ith more recent studies and more advanced technologies.
e should acknowledge that the meta-analysis was not
igure 2. Summary receiver-operating characteristic curves for the diagno
tandard of X-ray angiography using segment-level data according to coro
ight (D) coronary arteries. Setup as in Figure 1.owered to detect modest subgroup differences and such sifferences might have been missed. Alternatively, these
arameters may not be very important for the overall
iagnostic accuracy of CMRA. If anything, we noted
on-statistically significant trends for better diagnostic per-
ormance in earlier studies with less advanced techniques. If
his is not a chance finding, it may reflect intangible
ifferences in the subject selection process, center expertise
nd performance, and changes in the criteria used to
haracterize CMRA as “evaluable” or not. The single
ulticenter study reported to date demonstrated 93% sen-
erformance of coronary magnetic resonance angiography against the gold
essel: left main (A), left anterior descending (B), left circumflex (C), andstic p
nary vitivity and 42% specificity at the subject level (29). These
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Magnetic Resonance Angiography to Diagnose CAD November 2, 2004:1867–76alues reflect a higher sensitivity and lower specificity than
he main meta-analysis estimates, but the tradeoff is of fairly
imilar magnitude. The anticipated negative predictive val-
es based on the results of the multicenter study would be
lightly more optimistic than those of the meta-analysis at
retest CAD probabilities of 20% (4% vs. 5%) or 50%
14.3% vs. 18%), but the differences are not large. The
eta-analysis demonstrates in a much larger sample size
approximately a log scale higher than that of the multi-
enter study) that CMRA holds clinical promise across a
ider range of diverse clinical centers.
The published reports on the diagnostic performance of
MRA are quite heterogeneous regarding study design and
nalytic methodologies. For example, evaluation of CAD
as been performed in different ways (subject level vs. vessel
evel vs. segment level). However, heterogeneity is not
ecessarily a limitation in meta-analysis (49), and it provides
key opportunity to show the consistent performance of the
ethod. We should also acknowledge that not all reports
rovided complete data. Nevertheless, we contacted several
nvestigators to obtain clarifications or additional data that
nhanced our analyses. More rigorous reporting of future
linical research on coronary artery imaging technologies
hould be encouraged. Our study attempted to address
ssues pertaining to different analytic approaches by per-
orming separate analyses for each level. These results are
argely consistent and show the anticipated increase in
ensitivity and decrease in specificity as one moves from
egments to vessels to subjects.
Table 4. Subgroup Analyses of Evaluable Segm
95% CI
Subgroups Studies (
Acquisition technique
2-dimensional 4 (605)
3-dimensional 23 (4,22
Respiratory motion compensation
Breath holding 9 (1,54
Retrospective navigator 13 (2,00
Prospective navigator 5 (1,07
Publication year
2001 12 (2,11
2000 15 (2,50
Non-CAD subjects
Included 18 (3,27
Not included 9 (1,34
Distal segments
Considered 5 (568)
Not considered 22 (4,05
Blinding stated
Test and clinical data 12 (1,64
Test only 10 (1,60
None 5 (1,36
Sample size
200 segments 7 (2,30
200 segments 20 (2,31
*Statistically significant (p  0.10) between-study heterogen
CAD  coronary artery disease; CI  confidence intervaThe vast majority of the included studies did not evaluate sistal segments of the coronary vessels. As CMRA cannot
et visualize well the distal coronaries and branch vessels, its
iagnostic performance may be lower for lesions in these
egments. Until CMRA improves technically to the point
here its performance for distal stenoses can be reliably
valuated, the clinical use of CMRA should only be re-
tricted to proximal vessels. This may be adequate for many
atients, as the decision regarding surgical therapy of CAD
requently relies on the presence of proximal stenoses. Even
or the proximal coronary arteries, however, current tech-
ology only allows for evaluation of roughly 80% of the
maged segments. This limitation, also shared by other
oninvasive approaches (32,50–52), is an important consid-
ration for the widespread use of these approaches as
lternatives to conventional angiography.
Our findings should be used cautiously when attempting
o support the clinical utility of the method. Large intra-
enter differences likely make the technique still very much
enter-dependent and, therefore, larger experience is still
equired. Though various magnetic resonance imaging ap-
roaches have been described for coronary artery imaging,
urrent published experience only involves gradient echo
“bright blood”) techniques. With this methodology, nor-
ally flowing blood appears bright and stenoses/occlusions
ppear dark. Such techniques have known pitfalls. For
xample, coronary artery calcifications may cause suscepti-
ility artifacts and present as signal voids, erroneously
uggesting the presence of significant stenoses. Other ap-
roaches (black blood imaging, spiral imaging, enhanced
Level Data: Random Effects Estimates and
Weighted
Sensitivity
Weighted
Specificity
80% (65%–90%)* 91% (76%–97%)*
72% (67%–76%)* 86% (80%–90%)*
78% (69%–84%)* 91% (84%–95%)*
71% (65%–77%)* 80% (71%–87%)*
70% (54%–82%)* 89% (69%–96%)*
71% (63%–77%)* 83% (74%–89%)*
74% (68%–80%)* 88% (80%–93%)*
71% (64%–78%)* 88% (82%–93%)*
74% (69%–79%)* 79% (66%–88%)*
64% (46%–79%)* 93% (88%–96%)*
74% (70%–78%)* 83% (77%–88%)*
71% (65%–77%)* 80% (71%–87%)*
75% (67%–83%) 91% (81%–96%)*
72% (59%–82%)* 84% (67%–93%)*
76% (69%–82%)* 83% (70%–91%)*
71% (65%–77%)* 87% (80%–91%)*ent-
n)
3)
6)
0)
4)
2)
8)
2)
8)
2)
8)
4)
8)
2)
8)equences, high field imaging) (53–55) may offer additional
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November 2, 2004:1867–76 Magnetic Resonance Angiography to Diagnose CADalue. Imaging of the coronary vessel wall and atheroscle-
otic plaque (56–58) may also enhance our ability to
nderstand the pathophysiology of atherosclerosis and im-
act on its course, to improve patients’ outcomes. The utility
f such approaches remains to be proven. The merits of
MRA would also have to be evaluated against other
ompeting noninvasive coronary artery imaging technolo-
ies, and in particular computed tomography-based ap-
roaches, such as electron-beam and multislice spiral com-
uted tomography (32,50–52,59,60).
In conclusion, across many studies CMRA has shown
oderately high sensitivity and may have satisfactory neg-
tive predictive value for excluding significant major epicar-
ial coronary artery stenoses in subjects with suspected
AD. Coronary magnetic resonance angiography may have
alue for exclusion of significant multivessel CAD in sub-
ects referred for diagnostic catheterization, but the available
ata do not suffice to introduce CMRA as a widely applied
creening tool, particularly for individuals with low likeli-
ood of CAD.
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